MapLight Therapeutics, Inc. — insider transactions

5 transactions on record · CIK 1770069

Aggregates

computed from the filings below
Purchases, 12m
5
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
no sales recorded
Distinct insiders, 12m
2
Bought, 3m
$15.5M
Sold, 3m
$0
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$13M
2026-07-30
Director share, 12m
20.0%
of transactions where role is stated
Current run
5 buys
consecutive same-direction transactions
Net 3m flow
$15.5M
purchases minus sales
Total on record
5

Transactions

5 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-302026-07-282Catalyst4, Inc.10% OwnerOpen market purchase65,137$11.69$761.4Kfiling
2026-07-302026-07-282Catalyst4, Inc.10% OwnerOpen market purchase141,088$10.74$1.5Mfiling
2026-07-302026-07-300Catalyst4, Inc.10% OwnerOpen market purchase1,000,000$13.00$13Mfiling
2026-07-302026-07-291Catalyst4, Inc.10% OwnerOpen market purchase3,000$12.63$37.9Kfiling
2026-07-282026-07-280Cox TroyDirectorOpen market purchase15,620$9.52$148.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

MapLight Therapeutics, Inc. insider transactions — 5 filings on record — Tapewire